Oncolytic virotherapy in hematopoietic stem cell transplantation.

Human Immunology
Mohammad Hossein KazemiMohsen Hamidpour

Abstract

Hematopoietic stem cell transplantation (HSCT) is a curative option for various hematologic malignancies. However, fatal complications, such as relapse and graft-versus-host disease (GVHD) hampered favorable HSCT outcomes. Cancer cells remained in the body following the conditioning regimen, or those contaminating the autologous graft can cause relapse. Although the relapse is much lesser in allogeneic HSCT, GVHD is still a life-threatening complication in this type of HSCT. Researchers are seeking various strategies to reduce relapse and GVHD in HSCT with minimum effects on the engraftment and immune-reconstitution. Oncolytic viruses (OVs) are emerging anti-cancer agents with promising results in battling solid tumors. OVs can selectively replicate in the malignant cells in which the antiviral immune responses have defected. Hence, they could be used as a purging agent to eradicate the tumoral contamination of autologous grafts with no damages to hematopoietic stem cells. Moreover, they have been shown to alleviate GVHD complications through modulating alloreactive T cell responses. Primary results promise using OVs as a strategy to reduce both relapse and GVHD in the HSCT without affecting hematologic and immunologic engraftm...Continue Reading

References

Dec 1, 1992·Journal of Leukocyte Biology·L W TerstappenM E Medof
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G P RiceM B Oldstone
Nov 13, 1998·Science·M C CoffeyP W Lee
Feb 23, 2000·Journal of Virology·D M ShayakhmetovA Lieber
Jul 13, 2004·Reviews in Medical Virology·Neelam DhimanGregory A Poland
Apr 23, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hillard M LazarusAndrea Bacigalupo
Jan 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aurélie TrenadoJosé L Cohen
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Krishna V KomanduriRichard E Champlin
Apr 26, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andrea BacigalupoUNKNOWN Gruppo Italiano Trapianti Midollo Osseo (GITMO)
Mar 30, 2007·British Journal of Haematology·Gough G AuDarren R Shafren
Apr 26, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paola MarcatoPatrick Wk Lee
Jul 24, 2008·Bone Marrow Transplantation·C MessinaUNKNOWN EBMT Paediatric Working Party
Apr 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Assia L AngelovaZahari Raykov
Oct 1, 2009·Human Gene Therapy·Julien S SenacMichael A Barry
Mar 10, 2010·Cytokine & Growth Factor Reviews·Masmudur M RahmanGrant McFadden
Mar 12, 2010·Cytokine & Growth Factor Reviews·Marianne M StanfordMarkus J V Vähä-Koskela
Jul 17, 2010·The Journal of Infectious Diseases·Pablo J van de BergIneke J ten Berge
Mar 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bella PatelAdele K Fielding
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ulrike BacherMichael R Bishop
Apr 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eric BarteeGrant McFadden
Jul 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chandini M ThirukkumaranDon G Morris
Nov 8, 2012·Future Oncology·Jessica A CintoloBrian J Czerniecki
Feb 8, 2013·Journal of Virology·Winnie M ChanGrant McFadden
May 30, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David P ConradHarold L Atkins
Jun 4, 2013·Vaccine·Winnie M ChanGrant McFadden
Aug 27, 2013·Bone Marrow Transplantation·C M ThirukkumaranD G Morris
May 16, 2015·Mediators of Inflammation·Keishiro AmanoYoshihiro Komada
Sep 2, 2015·Nature Reviews. Drug Discovery·Howard L KaufmanAndrew Zloza
May 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Veronika BachanovaSarah A Cooley
Oct 14, 2016·Leukemia & Lymphoma·Jonathan U Peled, Robert R Jenq
Feb 12, 2017·Cell·Wendell A Lim, Carl H June
Jun 4, 2017·American Journal of Clinical Dermatology·Reinhart Speeckaert, Nanja van Geel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Giuseppina Li PiraMauro Montanari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A BosiAcute Leukemia Working Party of the European Blood and Marrow Transplant Group
© 2021 Meta ULC. All rights reserved